These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28446459)

  • 61. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
    Elmarakby AA; Faulkner J; Al-Shabrawey M; Wang MH; Maddipati KR; Imig JD
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1307-17. PubMed ID: 21832210
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
    Gangadharan Komala M; Gross S; Mudaliar H; Huang C; Pegg K; Mather A; Shen S; Pollock CA; Panchapakesan U
    PLoS One; 2014; 9(11):e108994. PubMed ID: 25369239
    [TBL] [Abstract][Full Text] [Related]  

  • 63. P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy.
    Ma F; Wu J; Jiang Z; Huang W; Jia Y; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1272-1281. PubMed ID: 30959066
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of macrophage-dependent peroxisome proliferator-activated receptor γ signalling on adhesion formation after abdominal surgery in an experimental model.
    Hong GS; Schwandt T; Stein K; Schneiker B; Kummer MP; Heneka MT; Kitamura K; Kalff JC; Wehner S
    Br J Surg; 2015 Nov; 102(12):1506-16. PubMed ID: 26313905
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
    Lv SS; Liu G; Wang JP; Wang WW; Cheng J; Sun AL; Liu HY; Nie HB; Su MR; Guan GJ
    Int Immunopharmacol; 2013 Oct; 17(2):275-82. PubMed ID: 23791972
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.
    Barutta F; Bellini S; Mastrocola R; Gambino R; Piscitelli F; di Marzo V; Corbetta B; Vemuri VK; Makriyannis A; Annaratone L; Bruno G; Gruden G
    Br J Pharmacol; 2018 Dec; 175(23):4371-4385. PubMed ID: 30184259
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice.
    Wu J; Guan TJ; Zheng S; Grosjean F; Liu W; Xiong H; Gordon R; Vlassara H; Striker GE; Zheng F
    Lab Invest; 2011 Oct; 91(10):1459-71. PubMed ID: 21808238
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation.
    Sun H; Tian J; Xian W; Xie T; Yang X
    Inflammation; 2015 Oct; 38(5):1739-47. PubMed ID: 25761429
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
    Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protective role of renal nerves in the development of diabetic nephropathy.
    Matsuoka H
    Diabetes Res; 1993; 23(1):19-29. PubMed ID: 7924145
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extracellular signal-regulated kinase (ERK) inhibition decreases arginase activity and improves corpora cavernosal relaxation in streptozotocin (STZ)-induced diabetic mice.
    Nunes KP; Toque HA; Caldwell RB; Caldwell RW; Webb RC
    J Sex Med; 2011 Dec; 8(12):3335-44. PubMed ID: 21995824
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
    Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
    Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice.
    Iacobini C; Menini S; Blasetti Fantauzzi C; Pesce CM; Giaccari A; Salomone E; Lapolla A; Orioli M; Aldini G; Pugliese G
    Br J Pharmacol; 2018 Jan; 175(1):53-66. PubMed ID: 29053168
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 77. Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathy.
    Yung S; Chau MK; Zhang Q; Zhang CZ; Chan TM
    PLoS One; 2013; 8(1):e54501. PubMed ID: 23349910
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The heme oxygenase system suppresses perirenal visceral adiposity, abates renal inflammation and ameliorates diabetic nephropathy in Zucker diabetic fatty rats.
    Ndisang JF; Jadhav A; Mishra M
    PLoS One; 2014; 9(1):e87936. PubMed ID: 24498225
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
    Tan AL; Sourris KC; Harcourt BE; Thallas-Bonke V; Penfold S; Andrikopoulos S; Thomas MC; O'Brien RC; Bierhaus A; Cooper ME; Forbes JM; Coughlan MT
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.